DHDDS and NUS1 : A Converging Pathway and Common Phenotype
Movement Disorders Clinical Practice · 2024
DOI: 10.1002/mdc3.13920 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Movement Disorders Clinical Practice, 2024. Verfasst von Laura J Williams und 11 weiteren Autor:innen. Beteiligte Einrichtung: Movement Disorder Unit, Department of Neurology, Westmead Hospital, Westmead, New South Wales, Australia. Hauptthemen laut MEDLINE: Myoclonus, Movement Disorders. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Variants in dehydrodolichol diphosphate synthetase ( DHDDS ) and nuclear undecaprenyl pyrophosphate synthase 1 ( NUS1 ) cause a neurodevelopmental disorder, classically with prominent epilepsy. Recent reports suggest a complex movement disorder and an overlapping phenotype has been postulated due to their combined role in dolichol synthesis. Cases We describe three patients with heterozygous variants in DHDDS and five with variants affecting NUS1 . They bear a remarkably similar phenotype of a movement disorder dominated by multifocal myoclonus. Diagnostic clues include myoclonus exacerbated by action and facial involvement, and slowly progressive or stable, gait ataxia with disproportionately impaired tandem gait. Myoclonus is confirmed with neurophysiology, including EMG of facial muscles. Literature Review Ninety‐eight reports of heterozygous variants in DHDDS, NUS1 and chromosome 6q22.1 structural alterations spanning NUS1 , confirm the convergent phenotype of hypotonia at birth, developmental delay, multifocal myoclonus, ataxia, dystonia and later parkinsonism with or without generalized epilepsy. Other features include periodic exacerbations, stereotypies, anxiety, and dysmorphisms. Although their gene products contribute to dolichol biosynthesis, a key step in N‐glycosylation, transferrin isoform profiles are typically normal. Imaging is normal or non‐specific.
Conclusions
Recognition of their shared phenotype may expedite diagnosis through chromosomal microarray and by including DHDDS/NUS1 in movement disorder gene panels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Movement Disorder Unit, Department of Neurology, Westmead Hospital, Westmead, New South Wales, Australia.
- TY Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
- School of Medicine Sydney, The University of Notre Dame, Sydney, New South Wales, Australia.
- Department of Genomic Medicine, Westmead Hospital, Westmead, New South Wales, Australia.
- The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Department of Neurology, Sydney Children's Hospital, Randwick, New South Wales, Australia.
ORCID-Profile: Laura J Williams, Hugo Morales-Briceño, Victor S C Fung
Zitieren
APA
Williams, L. J., Waller, S., Qiu, J., Innes, E., Elserafy, N., Procopis, P., Sampaio, H., Mahant, N., Tchan, M. C., Mohammad, S. S., Morales-Briceño, H., & Fung, V. S. C. (2024). DHDDS and NUS1 : A Converging Pathway and Common Phenotype. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13920
Vancouver
Williams LJ, Waller S, Qiu J, Innes E, Elserafy N, Procopis P, et al. DHDDS and NUS1 : A Converging Pathway and Common Phenotype. Movement Disorders Clinical Practice. 2024. doi:10.1002/mdc3.13920
BibTeX
@article{Williams2024,
author = {Williams, Laura J and Waller, Sophie and Qiu, Jessica and Innes, Emily and Elserafy, Noha and Procopis, Peter and Sampaio, Hugo and Mahant, Neil and Tchan, Michel C and Mohammad, Shekeeb S and Morales-Briceño, Hugo and Fung, Victor S C},
title = {DHDDS and NUS1 : A Converging Pathway and Common Phenotype},
journal = {Movement Disorders Clinical Practice},
year = {2024},
doi = {10.1002/mdc3.13920}
}
EUVIMED